Literature DB >> 10618702

Twenty years of p53 research: structural and functional aspects of the p53 protein.

P May1, E May.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10618702     DOI: 10.1038/sj.onc.1203285

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


× No keyword cloud information.
  126 in total

1.  p53-dependent S-phase damage checkpoint and pronuclear cross talk in mouse zygotes with X-irradiated sperm.

Authors:  Tsutomu Shimura; Masao Inoue; Masataka Taga; Kazunori Shiraishi; Norio Uematsu; Norihide Takei; Zhi-Min Yuan; Takashi Shinohara; Ohtsura Niwa
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

2.  Viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus binds to p53 and represses p53-dependent transcription and apoptosis.

Authors:  T Seo; J Park; D Lee; S G Hwang; J Choe
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

3.  Mechanisms of 5-azacytidine (5AzC)-induced toxicity in the rat foetal brain.

Authors:  Masaki Ueno; Kei-Ichi Katayama; Hiroyuki Nakayama; Kunio Doi
Journal:  Int J Exp Pathol       Date:  2002-06       Impact factor: 1.925

Review 4.  [EEF1A2 inhibits the p53 function in hepatocellular carcinoma via PI3K/AKT/mTOR-dependent stabilization of MDM4].

Authors:  T Longerich
Journal:  Pathologe       Date:  2014-11       Impact factor: 1.011

5.  The K-bZIP protein from Kaposi's sarcoma-associated herpesvirus interacts with p53 and represses its transcriptional activity.

Authors:  J Park; T Seo; S Hwang; D Lee; Y Gwack; J Choe
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

6.  A small molecule binding to the coactivator CREB-binding protein blocks apoptosis in cardiomyocytes.

Authors:  Jagat C Borah; Shiraz Mujtaba; Ioannis Karakikes; Lei Zeng; Michaela Muller; Jigneshkumar Patel; Natasha Moshkina; Keita Morohashi; Weijia Zhang; Guillermo Gerona-Navarro; Roger J Hajjar; Ming-Ming Zhou
Journal:  Chem Biol       Date:  2011-04-22

7.  Hypophosphorylation of Mdm2 augments p53 stability.

Authors:  Christine Blattner; Trevor Hay; David W Meek; David P Lane
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

8.  EEF1A2 inactivates p53 by way of PI3K/AKT/mTOR-dependent stabilization of MDM4 in hepatocellular carcinoma.

Authors:  Rossella Pellegrino; Diego F Calvisi; Olaf Neumann; Venkatesh Kolluru; Josephine Wesely; Xin Chen; Chunmei Wang; Torsten Wuestefeld; Sara Ladu; Nahla Elgohary; Justo Lorenzo Bermejo; Bernhard Radlwimmer; Martin Zörnig; Lars Zender; Frank Dombrowski; Matthias Evert; Peter Schirmacher; Thomas Longerich
Journal:  Hepatology       Date:  2014-03-27       Impact factor: 17.425

9.  Differential recognition by the tumor suppressor protein p53 of DNA modified by the novel antitumor trinuclear platinum drug BBR3464 and cisplatin.

Authors:  Jana Kasparkova; Miroslav Fojta; Nicholas Farrell; Viktor Brabec
Journal:  Nucleic Acids Res       Date:  2004-10-14       Impact factor: 16.971

10.  The presence of anti-p53 antibodies in sera prior to thoracic surgery in non small cell lung cancer patients: its implications on tumor volume, nodal involvement, and survival.

Authors:  Michael Bergqvist; Daniel Brattström; Kristina Lamberg; Patrik Hesselius; Johan Wernlund; Anders Larsson; Gunnar Wagenius
Journal:  Neoplasia       Date:  2003 Jul-Aug       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.